Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, New Jersey (Reuters) - Merck said on ...

While Merck & Co.’s Keytruda already boasts a pair of approvals to treat certain forms of endometrial cancer, a recent effort to prove the PD-1 inhibitor’s worth as a post-surgery add-on therapy in ...

Add Yahoo as a preferred source to see more of our stories on Google. An inverted uterus — a uterus that folds in on itself — is a serious, potentially deadly complication. (Illustration: Joamir ...

Merck said on Friday a combination therapy being developed with partner Eisai failed a late-stage trial testing it as a first-line treatment for a type of cancer in the uterus lining. This is the ...

You've probably never heard of uterine inversion — and fortunately, that's because it's rare. When it does happen, it occurs right after delivery and is considered an obstetric emergency. The good ...

(RTTNews) - Drug major Merck & Co. Inc. (MRK) announced Friday that KEYTRUDA plus chemotherapy met primary endpoint of progression-free survival or PFS as first-line therapy for advanced or recurrent ...

Merck's (NYSE:MRK) blockbuster drug Keytruda, with chemotherapy, met the main goal of progression free survival (PFS) in patients with a type of cancer of the uterus in a phase 3 trial. The study, ...

May 9 (Reuters) - Merck (MRK.N), opens new tab said on Thursday its therapy being tested in certain patients with a type of cancer in the uterus lining failed a late-stage trial. The drugmaker's ...

Dec 8 (Reuters) - Merck MRK.N said a combination therapy being developed with partner Eisai 4523.T failed a late-stage trial testing it as a first-line treatment for a type of cancer in the uterus ...

Some people assume that pregnancy and childbirth will be a smooth experience, and in many cases it is. But a small number of women experience a serious and potentially deadly complication known as an ...